Over 22,000 MAGNEZIX^® implants sold around the world, number of clients growing strongly - the company has now announced an important step in securing its extremely rapid development. 

Syntellix AG, an innovative medical technology company from Hannover, and the global technology leader in biotransformable metallic implants, continues its expansion. With its unique implants, which are transformed to bone within the body, the company is confident of being able to establish new standards in medicine. So far, over 22,000 implants (screws and pins) have been sold world-wide, and the number of clients and international sales markets continues to grow strongly - the company has now announced an important step in securing its extremely rapid development.

The annual general meeting of Syntellix AG in the middle of September adopted a resolution to acquire financing via a cash capital increase to fund its ambitious international expansion strategy, and comprehensive research activities.

The measure was a complete success: The new shares have already been completely placed The CEO of the company, Thomas Mayer, is particularly delighted that all of the main shareholders in the company fully participated in the capital measure and fully utilised their personal subscription rights. "We are delighted in the trust shown in this way by our shareholders, and their willingness to provide further support for our strategic growth and our vision."